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Abstract
Background A previous systematic review on prognostic
factors for knee osteoarthritis (OA) progression showed
associations for generalized OA and hyaluronic acid levels.
Knee pain, radiographic severity, sex, quadriceps strength,
knee injury, and regular sport activities were not associ-
ated. It has been a decade since the literature search of that
review and many studies have been performed since then
investigating prognostic factors for radiographic knee OA
progression.
Questions/purposes The purpose of this study is to pro-
vide an updated systematic review of available evidence
regarding prognostic factors for radiographic knee OA
progression.
Methods We searched for observational studies in
MEDLINE and EMBASE. Key words were: knee,
osteoarthritis (or arthritis, or arthrosis, or degenerative joint
disease), progression (or prognosis, or precipitate, or pre-
dictive), and case-control (or cohort, or longitudinal, or
follow-up). Studies fulfilling the inclusion criteria were
assessed for methodologic quality according to established
criteria for reviews on prognostic factors in muscu-
loskeletal disorders. Data were extracted and results were
pooled if possible or summarized according to a best-evi-
dence synthesis. A total of 1912 additional articles were
identified; 43 met our inclusion criteria. The previous re-
view contained 36 articles, thus providing a new total of 79
articles. Seventy-two of the included articles were scored
high quality, the remaining seven were low quality.
Results The pooled odds ratio (OR) of two determinants
showed associations with knee OA progression: baseline knee
pain (OR, 2.38 [95%CI, 1.74–3.27) andHeberden nodes (OR,
2.66 [95% CI, 1.46–8.84]). Our best-evidence synthesis
showed strong evidence that varus alignment, serum
hyaluronic acid, and tumor necrosis factor-a are associated
with knee OA progression. There is strong evidence that sex,
formerknee injury, quadriceps strength, smoking, running, and
regular performance of sports are not associated with knee OA
progression. Evidence for the majority of determined asso-
ciations, however, was limited, conflicting, or inconclusive.
Conclusions Baseline knee pain, presence of Heberden
nodes, varus alignment, and high levels of serum markers
hyaluronic acid and tumor necrosis factor-a predict knee
OA progression. Sex, knee injury, and quadriceps strength,
among others, did not predict knee OA progression. Large
variation remains in definitions of knee OA and knee OA
progression. Clinical studies should use more consistent
definitions of these factors to facilitate data pooling by
future meta-analyses.
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Introduction
The prevalence of osteoarthritis of the knee (OA) is in-
creasing worldwide and this burden will continue to
increase owing to aging of the general population [95].
Consequent to an increase in incidence is the rise in the
number of patients with knee OA who are prone to further
deterioration of the knee. It therefore is important to better
understand, control, and attempt to prevent further pro-
gression of disease in patients with knee OA.
In 2007, Belo et al. [4] published the first systematic re-
view on prognostic factors for progression of knee OA. They
found that generalized OA and hyaluronic acid levels were
associated with progression of knee OA. Knee pain, baseline
radiographic severity, sex, quadriceps strength, knee injury,
and regular sport activities were not associated. For the re-
maining factors the evidence was limited or conflicting.
Their literature search had been performed up to December
2003; however, many articles studying radiographic pro-
gression of knee OA have been published in the decade since
that review. Therefore, we performed an update of the sys-
tematic review of observational studies by Belo et al. [4] to
determine the currently available evidence on prognostic
factors for radiographic progression of knee OA.
Search Strategy and Criteria
Literature Search
In the review by Belo et al. [4], the search of the literature
had been performed in MEDLINE and EMBASE for all
available observational studies up to December 2003. We
searched in MEDLINE and EMBASE from December 2003
up to February 2013. Key words were: knee, osteoarthritis
(or arthritis, or arthrosis, or degenerative joint disease),
progression (or prognosis, or precipitate, or predictive), and
case-control (or cohort, or longitudinal, or follow-up). Ar-
ticles were reviewed for inclusion independently by two
authors (ANB and JNB or JR). The following inclusion
criteria were used: 85% or more of participants in the ana-
lyses for OA progression had radiographic evidence of knee
OA at baseline; the study investigated determinants asso-
ciated with radiographic knee OA progression; radiographic
progression was the outcome measure; the study had a case-
control or cohort design with a minimal 1-year followup;
full text of the article was available; the study was in Eng-
lish, Dutch, German, or French. Studies that observed the
incidence of knee OA were excluded. A detailed description
of our search strategy is available online (Appendix 1.
Supplemental materials are available with the online version
of CORR1). All articles were reviewed for inclusion inde-
pendently by two authors (ANB and JNB or JR). Studies that
used MRI features to define OA progression were excluded.
However, studies determining MRI features as prognostic
factors were included.
Methodologic Quality
The same methodologic quality assessment criteria as in
the original review by Belo et al. [4] were used for this
review (Table 1). These criteria were based on established
criteria used in systematic reviews of prognostic factors for
patients with musculoskeletal disorders and were described
by Lievense et al. [49], Scholten-Peeters et al. [69], and
Altman [1]. The criteria cover the internal validity and the
informativeness of the study. All included articles were
scored independently by two authors (ANB and JNB or
JR). Cohen’s kappa coefficient (j) was calculated to indi-
cate the interrater agreement.
Data Extraction
Study population characteristics, observed risk factors,
definitions of knee OA progression, and measures of as-
sociation were extracted.
Table 1. Methodologic quality assessment criteria
Study population
Description of source population
Valid inclusion criteria
Sufficient description of inclusion criteria
Followup
Followup at least 1 year
Prospective or retrospective data collection
Loss to followup B 20%
Information about loss to followup (selective for age, sex, or
severity)
Exposure
Exposure assessment blinded for the outcome
Exposure measured identically in the studied population at baseline
and followup
Outcome
Outcome assessment blinded for exposure
Outcome measured identically in the studied population at baseline
and followup
Analysis
Measure of association or measures of variance given
Adjusted for age, sex, and severity
Reprinted with permission of John Wiley and Sons from Belo JN,
Berger MY, Reijman M, Koes BW, Bierma-Zeinstra SM. Prognostic
factors of progression of osteoarthritis of the knee: a systematic re-
view of observational studies. Arthritis Rheum. 2007;57:13–26.
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Evidence Synthesis
Odds ratios (ORs), relative risks (RRs), or hazard ratios
(HRs) were pooled when there was consistency in defini-
tion of study population, measured determinants, and
assessed outcome (using Review Manager [RevMan],
Version 5.3; Copenhagen, Denmark: The Nordic Cochrane
Centre, The Cochrane Collaboration, 2014). We tested for
heterogeneity with the chi-square and I-square tests. If
heterogeneity was absent, a fixed effects model was applied
to calculate pooled OR through the Mantel Haenszel test.
In the absence of consistency among definitions for OA, a
best-evidence synthesis was used to summarize the data.
The level of evidence was based on the updated guidelines
by Furlan et al. [34] and was divided into the following
levels: (A) strong, ie, consistent ([ 75%) findings among
two or more high-quality studies; (B) moderate, ie, findings
in one high-quality study and consistent findings in two or
more low-quality studies; (C) limited, ie, findings in one
high-quality study or consistent findings in three or more
low-quality studies; and (D) conflicting or inconclusive
evidence, ie, less than 75% of the studies reported con-
sistent findings, or the results were based on only one
study. High quality was defined as a quality score of 9 or
greater ([ 65% of the maximal attainable score). When
performing the best-evidence synthesis, we only differen-
tiated between high- and low-quality studies.
Studies Included
Of the 1912 articles identified using our search strategy, 43
met the inclusion criteria [2, 5, 7, 11, 13, 19, 20, 25–28, 30,
35, 38–44, 46, 48, 50–52, 55, 57–62, 64–66, 73, 74, 78, 85,
88, 91–93]. Belo et al. reviewed 36 articles [3, 8, 12, 14–
16, 18, 21–24, 29, 31, 32, 37, 45, 47, 53, 54, 56, 63, 70–72,
75–77, 79–83, 87, 89, 94, 96]; therefore the total number
of included studies was 79, studying 59 different deter-
minants for the progression of knee OA (Table 2). Three
reviewers scored 559 items for the methodologic quality
assessment of the 43 newly included articles and agreed on
519 items (93%; j = 0.79). The 53 disagreements were
resolved in a single consensus meeting. Seventy-two of the
79 included articles were scored as high quality (score,
9–13), and only one article had the maximum attainable
score. The remaining seven were scored as low quality,
however no article was scored less than 6. Six different
criteria were used for the inclusion of participants with OA
and 13 definitions were applied to define radiographic OA
progression. Furthermore, there were differences in how
the determinants under study were measured, ie, con-
tinuous, dichotomous, or categorical with varying cut-off
points.
Study Results
Because of the large number of studied determinants (n =
59), we pragmatically grouped our findings into five dif-
ferent categories: systemic factors (Table 3); disease
characteristics (Table 4); intrinsic factors (Table 5); ex-
trinsic factors (Table 6); and markers (Table 7). Some
authors presented statistically significant associations to OA
progression, but used p values or regression coefficients as
measures of association [3, 5, 12, 14, 20, 21, 23, 31, 37, 41,
42, 44, 45, 47, 48, 52, 62, 63, 72, 74, 77, 80, 82, 85, 87, 93].
We chose to present only OR, RR, or HR as measures of
associations; however, we have tabulated whether there was
a significant association with OA progression in an article.
Sensitivity Analysis
For factors in which we were forced to use a best-evidence
synthesis, we conducted a sensitivity analysis to check
whether differences in sample size could have altered our
conclusions. Additionally we checked whether large vari-
ances in followup could have led to different conclusions.
Results
Summaries of the results for systemic factors, disease
characteristics, intrinsic factors, extrinsic factors, and
markers are available (Appendix 2. Supplemental material
is available with the online version of CORR1.).
Pooled Results
The presence of knee pain at baseline and Heberden nodes
were associated with the progression of knee OA. The pooled
ORs based on pools of studies with consistency among the
definitions for OA inclusion, OA progression, and the deter-
minant under study, were 2.38 for knee pain at baseline (95%
CI,1.74–3.27; I2 = 52%) (Fig. 1) and 2.66 for the presence of
Heberden nodes (95% CI, 1.46–8.84); I2 = 0%) (Fig. 2). Be-
cause of the large number of determinantswith only a restricted
number of studies per determinant and owing to lack of con-
sistency between the reviewed studies regarding inclusion
criteria, outcome measures, and measures of association, sta-
tistical pooling was not possible for the majority of the
determinants.
Best-evidence Synthesis
For the remaining determinants, we applied a best-evidence
synthesis, which showed that based on consistent findings
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Sharma et al. [78], 2010 950 30 K/L 63.6 ± 7.8 62 13
Brouwer et al. [13], 2007 169 72 K/L 66.4 ± 6.7 59 12
Cerejo et al. [16], 2002 230 18 K/L 64 ± 10.8 73 12
Dieppe et al. [21], 1997 415 37.6* K/L 65.3 68 12
Felson et al. [29], 2003 223 15 and 30 OARSI 66.2 ± 9.4 42 12
Madan-Sharma et al. [50], 2008 186 24 ACR criteria 60.2 81 12
McAlindon et al. [53], 1996 556 120 K/L 70.3 63 12
Sharma et al. [79], 2001 230 18 K/L, JSW 64.0 ± 11.1 75 12
Spector et al. [81], 1994 58 24 K/L 56.8 ± 5.9 100 12
Vilim et al. [87], 2002 48 36 K/L, JSW 62.8 (48–74) 71 12
Bagge et al. [3], 1992 74 48 K/L NR 57 11
Benichou et al. [5], 2010 67 12 OARSI 60 ± 9 64 11
Botha-Scheepers et al. [11], 2008 86 24 ACR criteria 61 80 11
Brandt et al. [12], 1999 82 31.5* K/L 70.1 70 11
Denoble et al. [20], 2011 69 36 K/L 64.5 ± 10.1 71 11
Dieppe et al. [23], 1993 60 60 cOA and rOA 62.2 ± 1.5 65 11
Dieppe et al. [22], 2000 349 96 K/L 65.3 68 11
Ledingham et al. [47], 1995 188 24 K/L 71 (34–91) 63 11
Miyazaki et al. [56], 2002 74 72 K/L, JSW 69.9 ± 7.8 81 11
Nevitt et al. [59], 2010 1754 30 K/L 63 ± 8 63 11
Niu et al. [61], 2009 2623 30 K/L 62.4 ± 8.0 59 11
Sharif et al. [72], 1995 75 60 K/L 64.2 ± 11.6 69 11
Sharif et al. [75], 1995 57 60 JSW NR NR 11
Sharif et al. [76], 2000 40 60 K/L 65.2 ± 9.9 61 11
Sharif et al. [74], 2004 115 60 K/L 63.6 ± 9.7 55 11
Sharif et al. [73], 2007 115 60 K/L 63.6 ± 9.7 55 11
Zhang et al. [96], 1998 551 96 K/L 71 (63–91) 100 11
Zhang et al. [94], 2000 473 96 K/L 71 (63–91) 100 11
Bettica et al. [8], 2002 216 48 Osteophytes, JSW NR 100 10
Cooper et al. [18], 2000 354 61.2* K/L 71.3 72 10
Dam et al. [19], 2009 138 21 ACR criteria 60 48 10
Doherty et al. [24], 1996 134 30 K/L 71 (41–88) 56 10
Duncan et al. [25], 2011 414 36 K/L 64.8 ± 8.1 51 10
Felson et al. [31], 1995 869 97.2* K/L 70.8 ± 5.0 64 10
Felson et al. [30], 2007 715 + 488 30 + 120 NR§, ACR criteria 53 + 66 53 + 40 10
Fraenkel et al. [32], 1998 423 48 K/L NR 67 10
Hart et al. [37], 2002 830 48 Osteophytes, JSW 54.1 ± 5.9 100 10
Kopec et al. [43], 2012 259 72 K/L NR 65 10
Lane et al. [45], 1998 55 108 Osteophytes, JSW 66 33 10
Larsson et al. [46], 2012 74 90 OARSI 50 (32–73) 18 10
Mazzuca et al. [51], 2006 319 30 K/L 60.0 ± 9.6 84 10
McAlindon et al. [54], 1996 640 120 K/L 70.3 64 10
Miyazaki et al. [55], 2012 84 96 K/L 72.3 ± 3.1 93 10
Muraki et al. [57], 2012 1313 40 K/L 68.7 ± 11.3 75 10
Nelsonet al. [58], 2010 329 60 K/L 61.9 ± 9.7 61 10
Pavelka et al. [63], 2000 139 60 K/L 59.1 ± 8.0 76 10
Reijman et al. [66], 2007 532 72 K/L 68.6 ± 7.0 68 10
Schouten et al. [70], 1992 239 146.4* K/L 57.2 ± 6.1 59 10
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in multiple high-quality studies, there seems to be strong
evidence that varus alignment, serum TNFa level, and
serum hyaluronic acid level are associated with radio-
graphic progression of knee OA. There also is strong
evidence that sex (female), former knee injury, quadriceps
strength, smoking, running, and regular performance of
sports are not associated with progression of knee OA.
There was moderate evidence showing that a higher
dietary intake of vitamin D is inversely associated with
progression of knee OA. Thus far, there is limited evidence
that ethnicity, metabolic syndrome, genetic components
adduction moment, meniscal damage, knee ROM, general
vitamin and b-carotene intake, serum levels IL-10 and
N-propeptide of type II collagen, synovial levels aggrecan
neoepitope amino acid sequence and IL-18, and fractal
dimension progression on radiographic fractal signature
analysis are associated with progression of knee OA. There
also is limited evidence that knee OA progression is not
associated with osteoporosis; past or present estrogen use;
uric acid concentrations; depression or anxiety; hand grip
(muscle) strength; bone marrow lesions or edema; menis-
cectomy; chondrocalcinosis; MRI-detected subchondral
bone cysts, cartilage loss, or joint effusion; AP knee laxity;
vitamin E intake; serum levels IL-1Ra and transforming













Sharma et al. [77], 2003 171 18 K/L 64.0 ± 11.1 74 10
Spector et al. [80], 1992 63 132 K/L 60 and 61 72 10
Spector et al. [82], 1997 845 48 K/L NR 100 10
Sugiyama et al. [83], 2003 110 48 JSW 50.2 ± 6.0 100 10
Wilder et al. [88], 2009 217 67.2* K/L 65.9 ± 9.6 61 10
Yoshimura et al. [91], 2012 1296 36 K/L 63 66 10
Zhai et al. [93], 2007 618 84 NR 56 -NR 10
Attur et al. [2], 2011 98 24 K/L 60.7 56 9
Bergink et al. [7], 2009 1248 72 K/L 66.2 ± 6.7 58 9
Bruyere et al. [14], 2003 157 36 ACR criteria 66.0 ± 7.3 76 9
Bruyere et al. [15], 2003 157 36 ACR criteria 66.0 ± 7.3 76 9
Felson et al. [27], 2005 270 30 K/L 66.6 ± 9.2 40 9
Golightly et al. [35], 2010 1583 72 K/L 60.9 ± 10.0 64 9
Harvey et al. [38], 2010 2964 30 K/L 62 ± 8 58 9
Haugen et al. [39], 2012 267 12 OARSI 61.0 ± 9.5 55 9
Kraus et al. [44], 2009 138 36 K/L NR 74 9
Le Graverand et al. [48], 2009 141 24 K/L 56 100 9
Mazzuca et al. [52], 2004 73 30 K/L 55.2 ± 5.8 100 9
Nishimura et al. [60], 2010 92 48 K/L 71 ± 4.7 61 9
Peregoy and Wilder [64], 2011 157 72 K/L 66.5 ± 8.7 56 9
Reijman et al. [65], 2004 237 72 K/L 69.1 ± 6.9 71 9
Schouten et al. [71], 1993 239 146 K/L 57.4 ± 6.3 59 9
Wolfe and Lane [89], 2002 583 31 + 102 ACR criteria 63.4 ± 11.8 77 9
Yusuf et al. [92], 2011 155 72 K/L 59.6 ± 7.5 85 9
Fayfman et al. [26], 2009 490 120 K/L 60.5 62 8
Felson et al. [28], 2004 227 30 K/L 66.4 ± 9.4 41 8
Hunter et al. [40], 2007 595 36 Clinical symptoms 73.6 ± 2.9 60 8
Valdes et al. [85], 2004 280 120 K/L 56.9 100 8
Kerkhof et al. [41], 2010 835 72 K/L 67 64 6
Kerna et al. [42], 2009 141 36 K/L NR 70 6
Pavelka et al. [62], 2004 89 24 ACR criteria 56.7 ± 7.2 66 6
OA = osteoarthritis; K/L = Kellgren-Lawrence score; OARSI = Osteoarthritis Research Society International atlas; ACR = American College of
Rheumatology; JSW = joint space width, cOA = clinical OA; rOA = radiographic OA; NR = not reported; *mean followup in months; §criteria
not reported for one of the cohorts.
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Conflicting evidence was found for the associations be-
tween kneeOA progression and age; low bone density; serum
insulin growth factor-1 level; baseline radiographic or clinical
OA severity; generalized osteoarthritis; duration of symp-
toms; valgus alignment or malalignment in general; past knee
injury; the presence of tibiofemoral osteophytes; BMI; leg
length inequality; serum vitamin D level; dietary intake of
vitamin C; serum C-reactive protein, IL-1b, keratan sulfate,
and serum cartilage oligometric matrix protein levels, and
urinary crosslinked C-telopeptide level. Inconclusive evi-
dence was found for the determined associations between
knee OA progression and the single nucleotide polymor-
phisms CILP_395 (cartilage intermediate-layer proteins) and
rs3740199, patellofemoral alignment, and serum pentosidine
levels. There also was inconclusive evidence for no asso-
ciations found between knee OA progression and the single
nucleotide polymorphisms rs1871054, ADAM12_48 (A dis-
integrin and matrix metalloproteinase domain 12), and
TNA_106 (tetranectin plasminogen-binding protein), and
serum levels of YKL-40 (chitinase-3-like protein 1), MMP-9
(matrix metalloproteinase-9); and TIMP-9 (tissue inhibitors
of metalloproteinase).
Sensitivity Analysis
In this analysis, we tested whether conclusions from
relatively small studies (less than 200) incorrectly influ-
enced conclusions drawn from larger studies with more
statistical power studying the same determinant, or that
results from studies with a relatively short followup (cutoff
24 months) altered conclusions from studies with a longer
followup. Our sensitivity analysis found that our conclu-
sions did not change across the range of clinically plausible
differences in followup duration or sample size regarding
the strong, moderate, or conflicting evidence we found for
the various presented determinants.
Discussion
We performed an updated systematic review of available
evidence regarding prognostic factors for radiographic
knee OA progression. We found that there is strong evi-
dence that baseline knee pain and Heberden nodes, varus
alignment, and high baseline serum levels of hyaluronic
acid and TNFa are predictive for knee OA progression.
There also seems to be strong evidence that sex (female),
former knee injury, quadriceps strength, smoking, running,
and regular performance of sports are not predictive for
progression of knee OA. For all other studied factors in our
review, the evidence is limited, conflicting, or inconclu-
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significant associations as associated prognostic factors.
However, several of the included articles had small sample
sizes, which consequently can lead to lower statistical
power and more often to failure to detect differences that
might be present.
A possible limitation to our inclusion criteria was ad-
dressed by Zhang et al. [97]. They reported that, unlike
randomized trials, observational studies of patients with
preexisting disease are subject to various biases that may
account for discrepancies found between risk factors for
disease incidence and progression. They hypothesized that
risk factors actually might exist for progressive knee OA
but that flaws in study design and the measure of disease
progression may prevent us from detecting risk factors
[97]. Having cited their article, it seems reasonable that
there is the possibility that we have not determined all risk
factors for progression of knee OA, because some factors
might not have achieved significance in multivariable
analyses in a study and thus were not included in our
evidence synthesis. Nonetheless, we believe we have
summarized all presently known risk factors of which a
possible association with knee OA progression has been
studied.
We acknowledge that when applying a best-evidence
synthesis, one might unjustly conclude that there may be
conflicting or strong evidence for or against an association
of the determinant under study with knee OA. We would
have preferred to pool the data of all included studies.
However, because of large variation in criteria used in the
articles for defining disease, or disease progression, pooling
of the data generally was not possible. We encountered six
different criteria that were used for the inclusion of OA
(Table 2). Another approximately 13 different definitions
were applied for OA progression (Tables 3–7). Further-
more, there were differences in how the determinants under
study were measured, (continuous, dichotomous, or cate-
gorical), and varying cutoff points were used. As
previously described, we pooled the results for ‘‘knee pain’’
and ‘‘Heberden nodes’’ for which both results showed as-
sociations with the progression of knee OA. This is
different from the conclusions we would have drawn from
a best-evidence synthesis, which would show conflicting
Fig. 1 A forest plot for the pooled odds ratio (OR) shows the
association between the presence of knee pain at baseline and
radiographic progression of knee osteoarthritis (OA). The OR can
deviate from the OR in Table 4 because pooled ORs were obtained
through crude ORs, as opposed to the adjusted OR in Table 4. The
results from Dieppe and Wolfe for pooling were not available and
were not included in this analysis. The results from the chi-square and
I2 tests indicate homogeneity between the studies. M–H = Mantel
Haenszel test; Fixed = fixed effects model; df = degrees of freedom.
Fig. 2 A forest plot for the pooled odds ratio (OR) shows the
association between the presence of Heberden nodes at baseline and
radiographic progression of knee osteoarthritis (OA). The OR can
deviate from that in Table 4 because pooled ORs were obtained
through crude ORs, as opposed to the adjusted OR in Table 4. The
results from the chi-square and I2 tests indicate homogeneity between
the studies. M–H = Mantel Haenszel test; Fixed = fixed effects model;
df = degrees of freedom.
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evidence for both determinants. In our opinion, it is likely
that more of the conflicting associations we presented are
attributable to the differences in definitions of knee OA or
knee OA progression. For example, the conflicting evi-
dence for BMI probably would be altered if statistical
pooling was feasible; given that all 11 significant risk es-
timates (OR/RR/HR) regarding BMI were positive
associations and that six of the 12 nonsignificant asso-
ciations also were positive associations, it seems likely that
if pooled, the combined overall association between BMI
and knee OA would be a positive, significant one. In ad-
dition, the conflicting evidence for age, seven of the 10
presented analyses (70%) showed no significant asso-
ciation, falling just short for the criteria for ascertaining
strong evidence ([ 75%) for no association between age
and OA progression.
In the original review by Belo et al. [4] and in a review
by van Dijk et al. [86], the evidence for association be-
tween varus alignment and OA progression was limited.
However, a couple studies have been performed since these
reviews were published that have determined significant
associations with varus alignment, which enabled us to
conclude that there is strong evidence for this finding. The
latter is in accordance with results published in later sys-
tematic reviews by Tanamas et al. [84] and Chapple et al.
[17]. Except for the original review by Belo et al., there are
to our knowledge no other reviews available that have
determined the predictive value of serum hyaluronic acid
levels and OA progression [9]. In addition, to our knowl-
edge, no reviews have been published assessing the
predictive value of serum level TNFa for knee OA
progression.
We found strong evidence that sex was not associated
with knee OA progression, as did Belo et al. [4]. This is in
contrast to the earlier reviews published by van Dijk et al.
[86] and Chapple et al. [17]. van Dijk et al. found limited
evidence for the absence of an association with sex, but
they included articles that used physical functioning as an
outcome measure. Chapple et al. found conflicting evi-
dence; however, their evidence was based on four analyses
of three studies, which also are included in our review [21,
47, 70]. Three of the four analyses were consistent (no
association); one was conflicting (significant association)
[47]. Our evidence synthesis was based on 10 analyses, of
which nine analyses were consistent (no association),
consequently outweighing the one conflicting finding. van
Dijk et al. and Chapple et al. reported limited evidence for
the absence of an association between quadriceps strength
and knee OA progression. This is consistent with our
finding; however, our conclusion is based on more evi-
dence. Consistent results also were found for regular
performance of sports, in which van Dijk et al. reported
limited and Chapple et al. reported strong evidence for
absence of an association. However, in articles by Fransen
and McConnell [33] and Bennell and Hinman [6] review-
ing the effect of exercise therapy in patients with knee OA,
the authors reported that exercise has a short-term benefit
in patients with knee OA, although the magnitude of the
reported benefit is small. This highlights the importance of
the need to understand the working mechanism of exercise
therapy.
A topic of considerable interest is the potential asso-
ciation between BMI and knee OA progression. Previous
reviewers have established a positive association between
BMI and incident knee OA [10, 95]. However, the evi-
dence for an association between BMI and progression of
knee OA remains conflicting in our review, which is con-
sistent with the findings by Belo et al. [4] and Chapple
et al. [17].
Noteworthy is the lack of overlap in evidence for
prognostic factors for hip and knee OA progression. In two
large reviews studying prognostic factors for hip OA,
Lievense et al. [49] provided strong evidence for an asso-
ciation between hip OA progression with type of hip
migration and with atrophic bone response. They also
presented strong evidence for the absence of an association
with BMI. Wright et al. [90] reported strong evidence for
association of hip OA progression with age, joint space
width at entry, femoral head migration, femoral osteo-
phytes, bony sclerosis, baseline hip pain, and certain hip
OA severity indexes. They also provided strong evidence
for the absence of an association with acetabular osteo-
phytes. The discrepancy between the findings for hip and
knee OA is unclear but could be attributable to the dif-
ference in the number of studies available determining risk
factors for progression of hip or knee OA [9].
Future research on the true relationship between prog-
nostic factors for radiographic progression of knee OA is
needed, mainly on the factors where conflicting evidence
was presented (eg, age, baseline OA severity, BMI). Fur-
thermore, we presented limited, inconclusive, or conflicting
evidence on many factors with potential associations with
OA progression. It would be important to investigate de-
terminants that can be influenced or modified to reduce the
risk of OA progression, perhaps including metabolic syn-
drome, bone marrow lesions, or osteoporosis. Moreover,
there would be obvious advantages to testing the effect of
new or existing disease-modifying pharmacologic or sur-
gical interventions in patients with an established increased
risk of OA progression.
We found strong evidence that baseline knee pain and
Heberden nodes, varus alignment, and high baseline serum
levels of hyaluronic acid and TNFa are predictive for knee
OA progression. Sex (female), former knee injury,
quadriceps strength, smoking, running, and regular per-
formance of sports are not predictive for progression of
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knee OA. Many studies have been performed and are being
performed determining risk factors for knee OA progres-
sion, but the variability in how OA and OA progression are
defined across the relevant studies remains an impediment
to pooling the available evidence. We strongly recommend
future researchers use uniform definitions of determinants,
disease, and disease progression; it would enable more
precise determination of possible risk factors for knee OA
progression through meta-analyses. The majority of the
included studies used the Kellgren-Lawrence classification
as definition of disease and disease progression. This
classification has been criticized because the criteria have
been described and interpreted differently in various stud-
ies [67]. However, the Kellgren-Lawrence criteria provide
a reliable classification of knee OA and OA progression,
given that the original description of the criteria are applied
[67, 68]. We therefore recommend that future researchers
use the Kellgren-Lawrence classification to define radio-
graphic OA and OA progression. Furthermore, considering
that some MRI scoring systems have been and currently are
being developed to define knee OA progression [36], it
seems preferable that the same MRI scoring system would
be used universally in future studies on prognostic factors
for knee OA progression. We would like to call on expert
committees, such as the Osteoarthritis Research Society
International (OARSI) for OA Imaging to announce their
recommendations on this important topic.
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